Cargando…

Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders

Objective: The present study aimed at comparing the prevalence of major psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, and generalized anxiety disorder between performance-enhancing drug users and nonuser bodybuilders. Moreover, the prevalence of major ps...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostovar, Afshin, Haerinejad, Mohammad Javad, Akbarzadeh, Samad, Keshavarz, Mojtaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816910/
https://www.ncbi.nlm.nih.gov/pubmed/29472947
_version_ 1783300777251438592
author Ostovar, Afshin
Haerinejad, Mohammad Javad
Akbarzadeh, Samad
Keshavarz, Mojtaba
author_facet Ostovar, Afshin
Haerinejad, Mohammad Javad
Akbarzadeh, Samad
Keshavarz, Mojtaba
author_sort Ostovar, Afshin
collection PubMed
description Objective: The present study aimed at comparing the prevalence of major psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, and generalized anxiety disorder between performance-enhancing drug users and nonuser bodybuilders. Moreover, the prevalence of major psychiatric disorders in bodybuilders was also reported. Method: In this study, 453 athletes were recruited from Bushehr bodybuilding gyms from February to May 2015. A structured questionnaire was used to collect the participants’ information, including demographic characteristics, sports’ status and performance-enhancing drug use. According to the condition of performance-enhancing drug use, the participants were divided into current users, non-current users, and nonusers. The psychiatric status of the participants was evaluated using DSM-IV diagnostic criteria for major depressive disorder, bipolar disorder, generalized anxiety disorder, and schizophrenia. We also asked about the acute psychotic disturbances after using performance-enhancing drugs, alcohol use, and history of aggressive behavior in bodybuilders. Data were analyzed using one-way analysis of variance and chi-square tests. Results: Prevalence of major depressive disorder, bipolar disorder, schizophrenia, generalized anxiety disorder, and the overall prevalence of psychiatric disorders in the bodybuilders was 19.7%, 3.8%, 1.5%, 16.6%, and 26.7%, respectively. After using performance-enhancing drugs, 33% of the bodybuilders had experienced acute psychological disturbances. There were no significant differences between current, non-current, and nonuser bodybuilding athletes in the measured psychiatric disorders. Conclusion: Prevalence of psychiatric disorders was not significantly different in performance-enhancing drug users and nonusers. Thus, it can be concluded that performance-enhancing drugs do not increase the risk of psychiatric disorders in bodybuilders.
format Online
Article
Text
id pubmed-5816910
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Psychiatry & Psychology Research Center, Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-58169102018-02-22 Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders Ostovar, Afshin Haerinejad, Mohammad Javad Akbarzadeh, Samad Keshavarz, Mojtaba Iran J Psychiatry Original Article Objective: The present study aimed at comparing the prevalence of major psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, and generalized anxiety disorder between performance-enhancing drug users and nonuser bodybuilders. Moreover, the prevalence of major psychiatric disorders in bodybuilders was also reported. Method: In this study, 453 athletes were recruited from Bushehr bodybuilding gyms from February to May 2015. A structured questionnaire was used to collect the participants’ information, including demographic characteristics, sports’ status and performance-enhancing drug use. According to the condition of performance-enhancing drug use, the participants were divided into current users, non-current users, and nonusers. The psychiatric status of the participants was evaluated using DSM-IV diagnostic criteria for major depressive disorder, bipolar disorder, generalized anxiety disorder, and schizophrenia. We also asked about the acute psychotic disturbances after using performance-enhancing drugs, alcohol use, and history of aggressive behavior in bodybuilders. Data were analyzed using one-way analysis of variance and chi-square tests. Results: Prevalence of major depressive disorder, bipolar disorder, schizophrenia, generalized anxiety disorder, and the overall prevalence of psychiatric disorders in the bodybuilders was 19.7%, 3.8%, 1.5%, 16.6%, and 26.7%, respectively. After using performance-enhancing drugs, 33% of the bodybuilders had experienced acute psychological disturbances. There were no significant differences between current, non-current, and nonuser bodybuilding athletes in the measured psychiatric disorders. Conclusion: Prevalence of psychiatric disorders was not significantly different in performance-enhancing drug users and nonusers. Thus, it can be concluded that performance-enhancing drugs do not increase the risk of psychiatric disorders in bodybuilders. Psychiatry & Psychology Research Center, Tehran University of Medical Sciences 2017-10 /pmc/articles/PMC5816910/ /pubmed/29472947 Text en Copyright © Psychiatry & Psychology Research Center, Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ostovar, Afshin
Haerinejad, Mohammad Javad
Akbarzadeh, Samad
Keshavarz, Mojtaba
Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
title Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
title_full Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
title_fullStr Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
title_full_unstemmed Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
title_short Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
title_sort comparison of the prevalence of psychiatric disorders in performance-enhancing drug users and nonuser bodybuilders
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816910/
https://www.ncbi.nlm.nih.gov/pubmed/29472947
work_keys_str_mv AT ostovarafshin comparisonoftheprevalenceofpsychiatricdisordersinperformanceenhancingdrugusersandnonuserbodybuilders
AT haerinejadmohammadjavad comparisonoftheprevalenceofpsychiatricdisordersinperformanceenhancingdrugusersandnonuserbodybuilders
AT akbarzadehsamad comparisonoftheprevalenceofpsychiatricdisordersinperformanceenhancingdrugusersandnonuserbodybuilders
AT keshavarzmojtaba comparisonoftheprevalenceofpsychiatricdisordersinperformanceenhancingdrugusersandnonuserbodybuilders